Cargando…
FoxP3- and CD8-positive Infiltrating Immune Cells Together Determine Clinical Outcome in Colorectal Cancer
Immune cells are known to affect clinical outcome in colorectal cancer. Subsets of immune cells can both support and inhibit immunological interaction with tumor cells. We examined the clinical impact of T cells that are supposed to be responsible for the down regulation of a T cell response: regula...
Autores principales: | Zeestraten, Eliane C. M., Van Hoesel, Anneke Q., Speetjens, Frank M., Menon, Anand G., Putter, Hein, van de Velde, Cornelis J. H., Kuppen, Peter J. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601218/ https://www.ncbi.nlm.nih.gov/pubmed/21732187 http://dx.doi.org/10.1007/s12307-011-0071-x |
Ejemplares similares
-
Prognostic Value of Polycomb Proteins EZH2, BMI1 and SUZ12 and Histone Modification H3K27me3 in Colorectal Cancer
por: Benard, Anne, et al.
Publicado: (2014) -
Histone trimethylation at H3K4, H3K9 and H4K20 correlates with patient survival and tumor recurrence in early-stage colon cancer
por: Benard, Anne, et al.
Publicado: (2014) -
Clinical impact of HLA class I expression in rectal cancer
por: Speetjens, Frank M., et al.
Publicado: (2007) -
Biomarkers in precision therapy in colorectal cancer
por: Reimers, Marlies S., et al.
Publicado: (2013) -
Spatial distribution of FoxP3+ and CD8+ tumour infiltrating T cells reflects their functional activity
por: Posselt, Rebecca, et al.
Publicado: (2016)